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Neuronal deletion of GSK3β increases
microtubule speed in the growth cone and
enhances axon regeneration via CRMP-2 and
independently of MAP1B and CLASP2
Márcia A Liz1, Fernando M Mar1,2, Telma E Santos1, Helena I Pimentel1, Ana M Marques1, Marlene M Morgado1,
Sílvia Vieira1, Vera F Sousa1,2, Hayley Pemble3, Torsten Wittmann3, Calum Sutherland4, James R Woodgett5 and
Mónica M Sousa1*
Abstract
Background: In the adult central nervous system, axonal regeneration is abortive. Regulators of microtubule dynamics
have emerged as attractive targets to promote axonal growth following injury as microtubule organization is pivotal
for growth cone formation. In this study, we used conditioned neurons with high regenerative capacity to further
dissect cytoskeletal mechanisms that might be involved in the gain of intrinsic axon growth capacity.
Results: Following a phospho-site broad signaling pathway screen, we found that in conditioned neurons with high
regenerative capacity, decreased glycogen synthase kinase 3β (GSK3β) activity and increased microtubule growth
speed in the growth cone were present. To investigate the importance of GSK3β regulation during axonal regeneration
in vivo, we used three genetic mouse models with high, intermediate or no GSK3β activity in neurons. Following spinal
cord injury, reduced GSK3β levels or complete neuronal deletion of GSK3β led to increased growth cone microtubule
growth speed and promoted axon regeneration. While several microtubule-interacting proteins are GSK3β substrates,
phospho-mimetic collapsin response mediator protein 2 (T/D-CRMP-2) was sufficient to decrease microtubule growth
speed and neurite outgrowth of conditioned neurons and of GSK3β-depleted neurons, prevailing over the effect of
decreased levels of phosphorylated microtubule-associated protein 1B (MAP1B) and through a mechanism unrelated
to decreased levels of phosphorylated cytoplasmic linker associated protein 2 (CLASP2). In addition, phospho-resistant
T/A-CRMP-2 counteracted the inhibitory myelin effect on neurite growth, further supporting the GSK3β-CRMP-2
relevance during axon regeneration.
Conclusions: Our work shows that increased microtubule growth speed in the growth cone is present in conditions
of increased axonal growth, and is achieved following inactivation of the GSK3β-CRMP-2 pathway, enhancing axon
regeneration through the glial scar. In this context, our results support that a precise control of microtubule dynamics,
specifically in the growth cone, is required to optimize axon regrowth.
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Background
In the central nervous system (CNS), axons mostly fail
to regenerate given the inhibitory environment and the
lack of activation of neuronal-intrinsic regeneration-
associated pathways. It is, however, possible to stimulate
the intrinsic growth capacity of CNS axons. When the
peripheral branch of a dorsal root ganglia (DRG) neuron
is injured prior to lesion to its central branch (condition-
ing lesion), the central axons can overcome the glial scar
inhibitory effect and regenerate [1]. Although several
molecules have been identified as required for the condi-
tioning effect, none was proven to be sufficient and ne-
cessary to mimic the conditioning lesion, probably as a
combination of various mechanisms is needed.
Microtubule organization is crucial for axon regener-
ation. While CNS axons respond to injury by forming a re-
traction bulb with a disorganized network of microtubules,
peripheral nervous system (PNS) axons form a growth
cone composed by a backbone of stable microtubules and
dynamic microtubules in the axon tip [2]. Pharmacological
destabilization of microtubules converts a growth cone into
a retraction bulb, and stabilization leads to the formation
of growth cone-like structures [2] and increases axonal
regeneration in vivo, after spinal cord injury (SCI) [3].
Accordingly, histone deacetylase 6 (HDAC6) inhibition en-
hances tubulin acetylation and promotes axon growth on
inhibitory substrates [4]. In contrast, it has been shown
that in the PNS, axons have a higher regenerative capacity
as they activate a program leading to the activation of his-
tone deacetylase 5 (HDAC5) and to a lower microtubule
stability close to the injury site [5].
Here, we further explored the mechanisms underlying
the gain of regenerative capacity in conditioned DRG
neurons and identified glycogen synthase kinase 3β
(GSK3β) as an important player in this process. GSK3β
is a serine/threonine kinase that phosphorylates several
microtubule-interacting proteins, namely collapsin response
mediator protein 2 (CRMP-2), microtubule-associated pro-
teins (MAP1B and tau), microtubule plus end-tracking pro-
teins (adenomatous polyposis coli and cytoplasmic linker
associated protein 2 (CLASP2)) and the microtubule-
depolymerizing factor stathmin [6]. The activity of GSK3β
is regulated by phosphorylation. Under resting conditions,
the kinase is constitutively active following phosphorylation
of its Tyr216 residue, located in the kinase domain [7]. The
mechanism of Tyr216 phosphorylation has been proposed
to correspond to an autocatalytic event [8] although in
neurons, kinases such as Pyk2 and Fyn have also been
proposed as responsible for this phosphorylation [9,10]. Ex-
posure of neuroblastoma cells to the general tyrosine phos-
phatase inhibitor ortho-vanadate led to increased levels of
Tyr216 phosphorylation, raising the hypothesis that a group
of yet unidentified tyrosine phosphatases might regulate the
phosphorylation of Tyr216 [11]. Nevertheless, regulation of
GSK3β activity is generally seen as resulting from inactiva-
tion by phosphorylation of its Ser9 residue [12]. In response
to extracellular signals that activate the phosphatidylinosi-
tide 3-kinase (PI3K) pathway, protein kinase B (AKT) is
activated triggering the inactivation of GSK3β by phosphor-
ylation of Ser9 [13].
The array of GSK3β substrates suggests that it is a key
kinase regulating microtubule dynamics and an attract-
ive molecule to study in the context of axon growth.
However, controversy exists regarding GSK3β modula-
tion during axonal regeneration as pharmacological in-
hibition of GSK3β was shown to promote either axonal
growth [14] or myelin-dependent axon outgrowth inhib-
ition [15]. While most data relating GSK3β and axonal
regeneration relied on semi-specific pharmacological in-
hibitors tested in vitro, to further determine the relevance
of GSK3β during axonal regeneration in vivo, we used
three GSK3β genetic mouse models with different levels
of kinase activity: constitutively active GSK3βSer9Ala
knockin (KI) mice [16], GSK3β knockout heterozygous
mice [17] and mice with neuron-specific deletion of
GSK3β. Our data show that increased microtubule dy-
namics in the growth cone are achieved following inacti-
vation of the GSK3β-CRMP-2 pathway, enhancing axon
regeneration through the glial scar.
Results
Decreased GSK3β activity through downregulation of
P-Tyr216 is related to increased axonal regeneration
We used the conditioning lesion model [1,18] to identify
mechanisms promoting axonal regeneration. For that we
analyzed DRGs from rats with either SCI or conditioning
lesion using a phospho-site broad signaling pathway screen
(Kinexus) that examines 38 phosphorylation sites in 32 key
signaling proteins. In the CL group, SCI was preceded one
week by a sciatic nerve transection. As previously described
[1], rats with conditioning lesion had an increased number
of dorsal column axons entering the glial scar (Figure 1A),
with some axons being capable of regenerating beyond the
rostral border of the scar. As expected [1,18], the condi-
tioning effect was also observed in vitro as conditioned
DRG neurons (CL; neurons isolated from rats with a sciatic
nerve transection performed one week prior to DRG re-
moval) had an increased neurite outgrowth (Figure 1B,C).
The analysis of the phospho-site broad signaling path-
way screen revealed that following conditioning lesion
increased P-AktSer473 (activated Akt), increased P-GSK3βSer9
(which negatively regulates GSK3β activity), and decreased
P-GSK3βTyr216 were present (Table 1). No differential
phosphorylation of GSK3α was found (Table 1). Combined,
these observations indicate that following a conditioning
lesion there is an overall decrease of GSK3β activity.
Validation was performed by Western blot in DRG
(Figure 1D,E,) where we also analyzed samples from
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Figure 1 Decreased GSK3β activity through downregulation of P-Tyr216 is related to increased axonal growth. (A) Representative
images of dorsal column fibers traced with cholera toxin B in sagittal sections following SCI (dorsal hemisection) or conditioning lesion (CL) in
rats; r: rostral; c: caudal; d: dorsal; v: ventral. Dashed lines label the border of the glial scar. Scale bar: 100 μm. (B) Representative images of neurite
outgrowth of naïve and conditioned rat DRG neurons (CL). Scale bar: 50 μm. (C) Quantification of B; (n = 40 to 92). (D) Western blot analysis
of P-AktSer473, P-GSK3βSer9 and P-GSK3βTyr216 on DRG extracts from uninjured rats (Un) or subjected to SCI or CL. (E) Quantification of D;
(n = 3 to 4). (F) Western blot analysis of P-GSK3βSer9 and P-GSK3βTyr216 in SCI site extracts from rats with SCI or conditioning lesion (CL);
(G) Quantification of F; (n = 5 to 7). (H) P-GSK3βTyr216 and GSK3β immunostaining of the growth cone of naïve rat DRG neurons or
conditioned (CL) neurons; (n = 10 to 12). Scale bar: 4 μm. (I) Western blot analysis of P-CRMP-2 on SCI site extracts from rats with SCI or
conditioning lesion (CL); (n = 4 to 7). (J) Western blot analysis of P-FynTyr530 on SCI site extracts from rats with SCI or conditioning lesion
(CL); (n = 4 to 5). (K) P-GSK3βTyr216 and GSK3β staining of the growth cone of control transfected DRG neurons or neurons transfected with
a Fyn kinase dead construct (Fyn KD); (n = 72 to 101). Scale bar: 3 μm. All error bars are SEM. *P <0.05. **P <0.01. ***P <0.001. Two-tailed
Student’s t test. CRMP-2, collapsin response mediator protein 2; DRG, dorsal root ganglia; GSK3β, glycogen synthase kinase 3β; SCI, spinal
cord injury; SEM, standard error of the mean.
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uninjured animals. After conditioning lesion, increased
P-AktSer473 was found relative to both uninjured DRG
and DRG collected after SCI (Figure 1D,E). Regarding
P-GSK3βSer9, although after SCI the levels were increased
relative to uninjured DRG, a more pronounced increase
was observed after conditioning lesion (Figure 1D,E). The
levels of P-GSK3βTyr216 were decreased after condition-
ing lesion, when compared to both uninjured DRG and
DRG collected after SCI (Figure 1D,E). Locally at the
SCI site no differences were found in P-GSK3βSer9,
while P-GSK3βTyr216 was decreased after conditioning
lesion (Figure 1F,G). Accordingly, in the growth cone of con-
ditioned DRG neurons a 1.9-fold decreased ratio (P <0.0001)
of P-GSK3βTyr216/GSK3βwas present (Figure 1H). The
decreased P-GSK3βTyr216 levels at the SCI site of rats
with conditioning lesion correlated with a 1.5-fold de-
crease in GSK3β kinase activity (P <0.05) and decreased
phosphorylation of CRMP-2 (Figure 1I).
Initial GSK3βTyr216 phosphorylation occurs through an
autocatalytic event [8], although the upstream kinases Pyk2
and Fyn can also target this residue [9,10]. Whereas we
did not detect Pyk2 either in the DRG or spinal cord, the
inactive form of Fyn kinase, P-FynTyr530, was increased
after conditioning lesion (Figure 1J; P <0.01). Moreover,
DRG neurons transfected with Fyn kinase dead (Fyn
Lys299Met) had a 1.6-fold decreased ratio (P <0.0001)
of P-GSK3βTyr216/GSK3β (Figure 1K) in support of a
Fyn kinase-mediated phosphorylation of GSK3βTyr216
under these conditions. Besides phosphorylation by Fyn
kinase, a 1.3-fold higher phosphatase activity against
P-GSK3βTyr216 was found in animals with condition-
ing lesion (P <0.05) further supporting a tight control
of the P-GSK3βTyr216 levels, probably achieved by
dual regulation of upstream kinases and phosphatases.
Enhanced axonal growth in conditioned DRG neurons is
related to increased microtubule growth speed in the
growth cone
Our results showed a downregulation of GSK3β activity
through decreased GSK3βTyr216 phosphorylation in condi-
tioned neurons. Given the involvement of GSK3β in micro-
tubule dynamics, the microtubule growth rate in naïve and
conditioned rat DRG neurons was measured. For that, we
visualized polymerizing microtubule ends by transfecting
neurons with the plus-tip binding protein EB3. When com-
pared to naïve neurons, after conditioning lesion, EB3
comets moved with a 1.8-fold increased speed (Figure 2A,B,
see also Additional file 1: Movie S1). Increased microtubule
growth speed in conditioned neurons [see Additional file 1:
Movie S1] correlated with increased neurite outgrowth
(Figure 1C). Moreover, by extending the imaging periods,
increased axon elongation and increased microtubule
growth speed were observed in conditioned neurons,
when compared to naïve neurons [see Additional file 2:
Movie S2 and Additional file 3: Figure S1]. Regarding
the number of growing microtubules, no differences
were observed between naïve and conditioned DRG
neurons (data not shown). Moreover, in accordance
with an increased microtubule growth speed in the
growth cone, we observed that the EB3 fluorescence was
located within a shorter distance from the growth cone tip
in conditioned neurons (Figure 2C,D). This suggests that
in conditioned neurons, growth of microtubules into the
peripheral domain of the growth cone is promoted. Over-
all, conditioned DRG neurons exhibited decreased GSK3β
activity through downregulation of P-GSK3βTyr216 and
increased microtubule growth speed and growth into the
peripheral domain of the growth cone.
In vivo, inhibition of GSK3β via Ser9 phosphorylation is
dispensable for gain of axonal regeneration capacity
Given that Ser9 has been widely considered the key regula-
tory residue of GSK3β [12], we used GSK3βSer9Ala
knockin (KI) mice [16] to further assess its role in vivo dur-
ing axonal regeneration. In these animals, the endogenous
Ser9 codon of GSK3β was changed to encode the non-
phosphorylatable Ala residue [16]. GSK3β activity in
the spinal cord of GSK3βSer9Ala KI mice was increased
1.8-fold when compared to wild type (WT) mice (P <0.05),
in agreement with the known inhibitory activity of Ser9
phosphorylation. In vitro, naïve GSK3βSer9Ala KI DRG
neurons displayed a similar neurite outgrowth to that of
naïve WT neurons and the percentage of longer neurites
was increased following conditioning lesion (Figure 3A). In
vivo, tracing of dorsal column fibers with cholera toxin
subunit B (CT-B) after a spinal cord dorsal hemisection
corroborated the in vitro data, with GSK3βSer9Ala KI
axons displaying a similar behavior to that of WT axons
(Figure 3B-D). For both genotypes, we observed negligible
axonal growth through the glial scar following SCI,
whereas an increased number of axons entering the glial
scar able to regenerate for longer distances were seen fol-
lowing conditioning lesion (Figure 3B-D). Neither WT nor
GSK3βSer9Ala KI mice showed axons extending rostrally
beyond the glial scar, as the conditioning effect is less ro-
bust in mice than in rats [19]. These findings demonstrate
that modulation of GSK3β through Ser9 phosphorylation
Table 1 Proteins from the GSK3β pathway differentially
regulated in DRG after CL when compared to SCI
CL/SCI
Protein kinase B alpha (Akt) [S473] 1,53
Glycogen synthase kinase 3 beta (GSK3β) [S9] 1,55
Glycogen synthase kinase 3 beta (GSK3β) [Y216] 0,53
Glycogen synthase kinase 3 alpha (GSK3α) [S21] 0,95
Glycogen synthase kinase 3 alpha (GSK3α) [Y279] 1,04
SCI, spinal cord injury; CL, conditioning lesion; DRG, dorsal root ganglia.
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is not required to induce axonal growth. Moreover, in the
SCI site, both WT and GSK3βSer9Ala KI mice were able
to regulate GSK3β activity through reduced phosphoryl-
ation of Tyr216 after conditioning lesion (Figure 3E). In ac-
cordance with decreased GSK3β kinase activity after
conditioning lesion, the levels of P-CRMP-2 were de-
creased in the SCI site of both WT and GSK3βSer9Ala KI
mice (Figure 3F). These results further support that down-
regulation of GSK3β activity through decreased Tyr216
phosphorylation represents the primary regulatory event
leading to increased axonal growth.
Partial reduction of GSK3β activity increases axonal
growth through the glial scar
To further demonstrate that decreased GSK3β activity is
related to increased axonal growth, we assessed axonal re-
generation in GSK3β knockout heterozygous mice (GSK3β
(+/−)) [17]. As expected, GSK3β (+/−) mice exhibit an ap-
proximately 50% reduction of GSK3β kinase activity in the
spinal cord (P <0.05). Assessment of axonal regeneration
of ascending dorsal column fibers after a dorsal spinal cord
hemisection by tracing with CT-B (Figure 4A) showed that
GSK3β (+/−) mice have an increased number of axons in-
side the glial scar (Figure 4C) and that these are capable of
regenerating for longer distances (WT: 39.0 ± 7.8, and
GSK3β (+/−): 111.7 ± 32.4 μm; P <0.05). The conditioning
lesion is a very useful model to understand mechanisms
underlying central axon regeneration and several mole-
cules initially identified using this paradigm were later found
to increase regeneration of other unrelated tracts. To evalu-
ate whether downregulation of GSK3β activity might pro-
mote axonal regeneration of other tracts, regeneration of
serotonergic axons was assessed. 5-Hydroxytryptamine (5-
HT) immunostaining of descending raphespinal serotoner-
gic axons after complete spinal cord transection (Figure 4B)
showed that the number of 5-HT-positive axons caudal to
the lesion site was increased 17.4-fold in GSK3β(+/−) mice
(Figure 4C). This demonstrates that in a non-sensory tract,
lower levels of GSK3β increase axonal regeneration through
and beyond the glial scar. Of note, the basal levels of 5-HT
immunostaining in uninjured spinal cords were similar be-
tween WT and GSK3β(+/−) mice (data not shown). The in-
creased regeneration of GSK3β(+/−) serotonergic axons
correlated with an improved recovery of open field loco-
motor activity (Figure 4D), as expected given the modula-
tion by serotonergic axons of the activity of spinal motor
systems [20]. Uninjured mice of both genotypes displayed
similar maximum locomotor scores. We excluded the possi-
bility that differences in axonal regeneration in GSK3β(+/−)
mice might be related to stimulation of astrocyte migration
[21] as the glial scar, assessed by the glial fibrillary acidic pro-
tein (GFAP)-negative area, remained similar between the
Figure 2 Microtubule growth speed is increased in the growth cone of conditioned DRG neurons. (A) Kymographs of single processes of
naïve and conditioned (CL) neurons transfected with EB3-GFP. Scale bar: 1 μm. (B) Quantification of microtubule growth speed in naïve and in
conditioned (CL) neurons transfected with EB3-GFP; (n = 140 to 170 microtubules). (C) Quantification of EB3-fluorescence intensity relative to the
distance to the growth cone tip in naïve and in conditioned (CL) neurons transfected with EB3-GFP; (n = 10 growth cones). For distances closer
to the leading edge (between 0.48 and 4.48 μm) the differences presented are statistically significant with P <0.05. (D) Representative images of
growth cones of naïve and in conditioned (CL) neurons transfected with EB3-GFP. The green line surrounds the leading edge of the cell. Scale
bar: 5 μm. All error bars are SEM. ***P <0.001. Two-tailed Student’s t test. CL, conditioned lesion; DRG, dorsal root ganglia; SEM, standard error of
the mean.
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Figure 3 In vivo, inhibition of GSK3β via Ser9 phosphorylation is dispensable for gain of axonal regeneration capacity. (A)
Quantification of neurite outgrowth, measured as the percentage of neurons with the longest axon within each range (<75 μm, 75 to 250 μm, or
≥250 μm), of naïve and conditioned (CL) DRG neurons from either WT or GSK3βSer9Ala KI mice (KI); (n = 29 to 100). (B) Representative images of
CT-B + fibers in sagittal spinal cord sections following SCI (left panels) or conditioning lesion (right panels) in WT (upper panels) and GSK3βSer9Ala
KI mice (lower panels). r: rostral; c: caudal; d: dorsal; v: ventral; arrowheads highlight axons regenerating rostrally to the SCI site. Dashed lines label
the border of the glial scar. Scale bar: 50 μm. (C) Quantification of the number of CT-B + dorsal column fibers able to enter the glial scar; (n = 4 to
6). (D) Quantification of the longest distance of regeneration of CT-B + dorsal column fibers scored from the border of the lesion; (n = 4 to 6).
(E) Quantification of P-GSK3βTyr216 in relation to total GSK3β, as assessed by western blot, in either WT or GSK3βSer9Ala KI mice subjected to
SCI (WT SCI or KI SCI) or conditioning lesion (WT CL or KI CL). Results are presented as a percentage of the SCI condition. (F) Quantification of
P-CRMP-2 in relation to total CRMP-2, as assessed by western blot, in either WT or GSK3βSer9Ala KI mice subjected to SCI (WT SCI or KI SCI) or
conditioning lesion (WT CL or KI CL); (n = 3 to 4). Results are presented as a percentage of the SCI condition. All error bars are SEM. *P <0.05.
**P <0.01. ***P <0.001. Two-tailed Student’s t test. CRMP-2, collapsin response mediator protein 2; DRG, dorsal root ganglia; GSK3β, glycogen
synthase kinase 3β; SCI, spinal cord injury; SEM, standard error of the mean; WT, wild type.
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two strains (data not shown). These results show that partial
reduction of GSK3β increases axonal growth following SCI.
Neuronal deletion of GSK3β promotes axonal
regeneration in the CNS
To avoid possible confounding effects of GSK3β depleted glia,
we used mice with an inducible GSK3β neuronal deletion
(cre+GSK3βlox/lox mice) generated by crossing GSK3βlox/
lox [22] with Slick-H mice (that is, mice that co-express both
inducible-CreERT2 and yellow fluorescent protein (YFP)
under the control of the Thy1 promoter) [23]. In these ani-
mals cre-positive neurons are YFP-positive. In the cre
+GSK3βlox/lox mice, GSK3β was deleted in 97% of the YFP+
DRG neurons (Figure 5A), which represented 40% of all DRG
neurons. We did not observe any compensation by alterations
in expression of the GSK3α isoform in the YFP+ cells of cre
+GSK3βlox/lox mice (data not shown). As expected, growth
cones of GSK3β depleted neurons had residual levels of P-
CRMP-2 and P-MAP1B (Figure 5B), probably accounted for
by phosphorylation by alternative kinases.
In vitro, DRG neurons from cre+GSK3βlox/lox mice had
increased neurite outgrowth with more neurons extending
longer neurites (≥200 μm) (Figure 5C). In vivo, after dorsal
spinal cord hemisection, tracing with CT-B of YFP+ dorsal
column fibers corroborated the in vitro findings, as
cre+GSK3βlox/lox mice had a 9.8-fold increased number of
CT-B+/YFP+ axons entering the glial scar (Figure 5D, E).
Moreover, the area of the lesion occupied by YFP+ axons
was increased 1.8-fold in cre+GSK3βlox/lox (Figure 5D,F).
Since following dorsal hemisection all the dorsal column fi-
bers were transected, CT-B+/YFP+ axons entering the glial
scar reflect axonal regeneration. In the case of CT-B−/YFP+
axons, we cannot discard increased collateral sprouting
arising from uninjured axons. We did not assess regener-
ation of raphespinal serotonergic axons as Slick-H mice do
not express Cre recombinase in this tract. Although unre-
lated to an in vivo regenerative effect of DRG axons, after
complete spinal cord transection, open field locomotor re-
covery was increased in cre+GSK3βlox/lox mice (Fig-
ure 5G), further supporting that neuronal deletion of
GSK3β promotes regeneration and/or sprouting of other
tracts besides the dorsal column tract. Uninjured mice of
both genotypes displayed similar maximum locomotor
scores. These data indicate that total deletion of GSK3β in
neurons increases axonal regeneration in the CNS within
the glial scar.
Decreased GSK3β activity leads to increased microtubule
growth speed in the growth cone
To establish a causal effect between decreased GSK3β ac-
tivity and altered microtubule dynamics in the growth cone,
we measured microtubule growth speed in GSK3β(+/−)
Figure 4 Partial reduction of GSK3β activity increases axonal growth through the glial scar. (A) Representative images of dorsal column
fibers traced with CT-B in sagittal sections following dorsal hemisection in WT or GSK3β(+/−) mice. r: rostral; c: caudal; d: dorsal; v: ventral. Dashed
lines label the border of the glial scar. Arrowheads highlight axons regenerating rostrally to the SCI site. Scale bar: 50 μm. (B) Representative
images of 5-HT-immunostained serotonergic axons (red) counterstained with DAPI (blue) observed caudal to the lesion site in sagittal spinal cord
sections following a complete transection in WT or GSK3β(+/−) mice; (n = 5 to 6). Scale bar: 50 μm. (C) Number of CT-B + dorsal column axons
able to enter the glial scar following dorsal hemisection (CT-B+) and of 5-HT-immunostained serotonergic axons observed caudal to the lesion
site following a complete transection (5-HT+) in WT or GSK3β(+/−) mice. (D) Basso Mouse Scale (BMS) open field test following a complete
spinal cord transection in WT and GSK3β(+/−) mice; (n = 6 to 7). All error bars are SEM. *P <0.05. Two-tailed Student’s t test. DAPI, 4′,6-diamidino-
2-phenylindole; GSK3β, glycogen synthase kinase 3β; SCI, spinal cord injury; SEM, standard error of the mean; WT, wild type; 5-HT, 5-hydroxytryptamine.
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DRG neurons. GSK3β(+/−) neurons had an increased
microtubule growth speed in the growth cone (Figure 6A,
see also Additional file 4: Movie S3) which correlated with
an increased axonal growth as seen by extending the
periods of imaging [see Additional file 5: Movie S4 and
Additional file 6: Figure S2], similar to what was observed in
conditioned DRG neurons (Figure 2B). With respect to the
number of EB3 comets, no differences were observed (data
not shown). Moreover, GSK3β(+/−) neurons presented EB3
fluorescence located within a shorter distance from the
growth cone tip (Figure 6B,C), supporting an increased
growth of microtubules into the peripheral domain of the
growth cone. Accordingly, a decreased ratio of acetylated
(stable)/tyrosinated (dynamic) microtubules in the growth
cones of GSK3β(+/−) neurons was found (Figure 6D,E). In
DRG neurons from cre+GSK3βlox/lox mice, increased
microtubule growth speed was present in the growth cone
(Figure 6F, see also Additional file 7: Movie S5) and also cor-
related with increased axonal growth (Figure 5C, see also
Additional file 8: Movie S6 and Additional file 9: Figure S3).
Moreover, cre+GSK3βlox/lox neurons also presented a
decreased ratio of acetylated/tyrosinated microtubules
(Figure 6G,H). Of note, whereas with GSK3β(+/−) neurons
EB3-GFP was used, with cre+ GSK3βlox/lox neurons EB3-
mCherry was employed as cre+ neurons are YFP+. The dif-
ferences in these constructs (details available in the
Methods), might underlie the differences found among
controls (WT and cre+GSK3βwt/wt) for the parameters
assessed. In summary, these results demonstrate that either
partial reduction or total deletion of GSK3β increases micro-
tubule dynamics in the growth cone that correlates with
increased axon growth.
Increased microtubule growth speed in the growth cone
of GSK3β depleted neurons is related to decreased
phosphorylation of CRMP-2
To determine the mechanism underlying the effect of
GSK3β in microtubule growth speed, we analyzed the
Figure 5 Neuronal GSK3β deletion increases axonal growth. (A) Representative images of GSK3β immunohistochemistry in DRG neurons
from cre+GSK3βwt/wt (cre+wt/wt) mice and cre+GSK3βlox/lox (cre+lox/lox). Scale bar: 50 μm. (B) Quantification of the intensity ratio of the
P-CRMP-2/βIII-tubulin and P-MAP1B/βIII-tubulin immunostainings depicted in C; CRMP-2/βIII-tubulin (n = 63 to 65 growth cones) and P-MAP1B/
βIII-tubulin (n = 70 to 77 growth cones). (C) Neurite outgrowth in naïve DRG neurons from cre+GSK3βwt/wt and cre+GSK3βlox/lox mice quantified
as the percentage of neurons with the longest axon within each range: <75 μm, 75 to 200 μm, or ≥200 μm; (n = 48 to 66). (D) Representative
images of sagittal spinal cord sections following dorsal hemisection, from cre+GSK3βwt/wt and cre+GSK3βlox/lox mice. YFP+ axons are shown in
green and dorsal column fibers traced with CT-B are labeled in red; higher magnifications of cre+GSK3βwt/wt and cre+GSK3βlox/lox showing the
YFP+/CT-B+ axons (arrowheads) within the glial scar are shown on the right. r: rostral; c: caudal; d: dorsal; v: ventral. Scale bar: 25 μm. (E) Number
of CT-B+YFP+ axons able to enter the glial scar in cre+GSK3βwt/wt and cre + GSK3βlox/lox mice; (n = 4 to 5). (F) Percentage of lesion area
occupied by YFP+ axons (% YFP within lesion area) in cre+GSK3βwt/wt and cre+GSK3βlox/lox mice; (n = 4 to 5). (G) Locomotor recovery in cre
+GSK3βwt/wt and cre+GSK3βlox/lox mice assessed by Basso Mouse Scale following complete spinal cord transection. All error bars are SEM.
*P <0.05. ***P <0.001. Two-tailed Student’s t test. CRMP, collapsin response mediator protein; GSK3β, glycogen synthase kinase 3β; MAP1B,
microtubule-associated protein 1B; SEM, standard error of the mean; YFP, yellow fluorescent protein.
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role of key GSK3β substrates, namely MAP1B, CLASP2
and CRMP-2. In DRG neuron cultures, the high per-
centage of satellite cells and the low efficiency of nucleo-
fection and transduction, preclude a straightforward
comparison between endogenous and overexpressed
protein levels. To allow the comparison of the relative
expression of the different mutants analyzed, transfec-
tion (for MAP1B and CRMP-2) or transduction (for
CLASP2) of a neuronal cell line was performed and re-
vealed similar levels of expression among different mu-
tants (Figure 7A).
Phosphorylation of MAP1B by GSK3β increases micro-
tubule dynamics in non-neuronal cells [24,25]. In neurons,
overexpression of either WT MAP1B or of the phospho-
resistant mutant ST/AA-MAP1B had no significant
impact in microtubule growth speed or in the ratio of
acetylated/tyrosinated microtubules (Figure 7B-D, see also
Additional file 10: Movie S7). However, the phospho-
mimetic mutant ST/DD-MAP1B increased microtubule
growth speed and led to a decreased ratio of acetylated/
tyrosinated microtubules (Figure 7B-D, see also Additional
file 10: Movie S7). As such, P-MAP1B in neurons is sufficient
Figure 6 Decreased GSK3β activity leads to increased microtubule dynamics in the growth cone. (A) Quantification of microtubule growth
speed in naïve DRG neurons from WT or GSK3β(+/−) mice transfected with EB3-GFP; (n = 61 to 107 microtubules). (B) Quantification of EB3-
fluorescence intensity relative to the distance to the tip of the growth cone, in naïve DRG neurons from WT or GSK3β(+/−) mice transfected with EB3-
GFP; (n = 10 growth cones). For distances between 0.80 to 1.12, 2.64 to 3.04, 4.64 to 7.04 μm the differences shown are statistically significant with P
<0.05. (C) Representative images of growth cones of naïve DRG neurons from WT or GSK3β(+/−) mice transfected with EB3-GFP. The green line
surrounds the leading edge of the cell. Scale bar: 4 μm. (D) Quantification of the intensity ratios between acetylated and tyrosinated microtubules in
WT or GSK3β(+/−) growth cones; (n = 101 growth cones). (E) Representative images of growth cones of naïve DRG neurons from WT or GSK3β(+/−)
mice immunostained with acetylated and tyrosinated α-tubulin. Scale bar: 5 μm. (F) Quantification of microtubule growth speed in naïve neurons
from cre+GSK3βwt/wt mice or cre+GSK3βlox/lox mice transfected with EB3-mCherry (n = 117 to 134 microtubules). (G) Quantification of the intensity
ratios between acetylated and tyrosinated microtubules in cre+GSK3βwt/wt or cre+GSK3βlox/lox growth cones; (n = 102 to 105 growth cones).
(H) Representative images of growth cones from cre+GSK3βwt/wt or cre+GSK3βlox/lox mice immunostained for acetylated and tyrosinated α-tubulin.
Scale bar: 5 μm. All error bars are SEM. ***P <0.001. Two-tailed Student’s t test. DRG, dorsal root ganglia; GFP, green fluorescent protein; GSK3β,
glycogen synthase kinase 3β; SEM, standard error of the mean. WT, wild type.
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but not necessary to increase microtubule dynamics, as in
GSK3β depleted neurons, reduced levels of P-MAP1B
(Figure 5C) and increased microtubule growth speed
co-exist.
CLASP2 is a microtubule plus end-binding protein that
when overexpressed in COS cells, promotes microtubule
stabilization [26]. GSK3β phosphorylates CLASP2 at mul-
tiple sites in the domain required for microtubule plus
end tracking, disrupting CLASP2 association with micro-
tubules [27]. DRG neurons overexpressing WT CLASP2
had an increased ratio of acetylated/tyrosinated microtu-
bules (Figure 7E,F). Viral transduction with CLASP2
Figure 7 Increased microtubule growth in GSK3β depleted neurons is related to decreased CRMP-2 phosphorylation. (A) MAP1B,
CLASP2 and CRMP-2 western in CAD cells. (B) Microtubule growth in rat neurons transfected with EB3-mCherry alone (control) or co-transfected
with WT MAP1B, ST/AA-MAP1B or ST/DD-MAP1B. (C) Intensity ratios between acetylated and tyrosinated microtubules in growth cones from rat
DRG neurons transfected with EB3-mCherry alone (control) or co-transfected with WT MAP1B, ST/AA-MAP1B or ST/DD-MAP1B. (D) Representative
images of C. Scale bar: 3 μm. (E) Intensity ratios between acetylated and tyrosinated microtubules in growth cones from rat naïve DRG neurons
either non-infected (control) or infected with WT CLASP2, 9S/A-CLASP2 or 8S/D-CLASP2. (F) Representative images of E. Scale bar: 3 μm.
(G) Microtubule growth in neurons transfected with EB3-GFP alone (control) or co-transfected with WT CRMP-2, T/A-CRMP-2, or T/D-CRMP-2.
(H) Intensity ratios between acetylated and tyrosinated microtubules in growth cones from neurons transfected with EB3-GFP alone (control) or
co-transfected with WT CRMP-2, T/A-CRMP-2, or T/D-CRMP-2. (I) Representative images of H. Scale bar: 5 μm. (J) Microtubule growth in naïve
neurons from cre+GSK3βwt/wt mice or cre+GSK3βlox/lox mice transfected with EB3-mCherry, or cre+GSK3βlox/lox mice co-transfected with
EB3-mCherry and T/D-CRMP-2 (cre+GSK3βlox/lox + T/D-CRMP-2). (K) Intensity ratios between acetylated and tyrosinated microtubules in
growth cones from cre+GSK3βwt/wt, cre+GSK3βlox/lox or cre+GSK3βlox/lox transfected with T/D-CRMP-2 (cre+GSK3βlox/lox + T/D-CRMP-2).
(L) Representative images of K. Scale bar: 5 μm. All error bars are SEM. *P <0.05. **P <0.01. ***P <0.001. ****P <0.0001. Two-tailed Student’s t test.
CLASP2, cytoplasmic linker associated protein 2; CRMP, collapsin response mediator protein; DRG, dorsal root ganglia; GSK3β, glycogen synthase
kinase 3β; MAP1B, microtubule-associated protein 1B; SEM, standard error of the mean. WT, wild type.
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followed by transfection with EB3 rendered neurons un-
healthy for subsequent analyses of microtubule growth
speeds. The phospho-resistant mutant 9S/A-CLASP2 pro-
moted an increase in the ratio of acetylated/tyrosinated
microtubules more pronounced than WT CLASP2, whereas
the phospho-mimetic mutant 8S/D-CLASP2 showed the
weakest effect (Figure 7E,F). These results agree with the
function of CLASP2 in promoting microtubule stability,
which is inhibited by GSK3β phosphorylation. As such, the
altered microtubule stability in GSK3β depleted neurons is
unrelated to decreased P-CLASP2, suggesting that an alter-
native GSK3β substrate is responsible for this effect.
CRMP-2 binds to tubulin heterodimers to promote
microtubule assembly, thereby enhancing axon elongation,
and its microtubule-binding activity is decreased upon
GSK3β phosphorylation [28]. In neurons, overexpression of
WT CRMP-2 or of the phospho-resistant mutant T/A-
CRMP-2 led to increased microtubule growth speed
(Figure 7G, see also Additional file 11: Movie S8), which
was reversed by transfection with the phospho-mimetic mu-
tant T/D-CRMP-2 (Figure 7G, see also Additional file 11:
Movie S8). Moreover, overexpression of CRMP-2 decreased
the ratio of acetylated/tyrosinated microtubules; this effect
being stronger when a phospho-resistant mutant (T/A-
CRMP-2) was used and less pronounced with the phospho-
mimetic mutant T/D-CRMP-2 (Figure 7H,I). These results
demonstrate that in neurons, the binding of CRMP-2 to
tubulin heterodimers in the growth cone controls the rate
of microtubule assembly and that this effect is negatively
regulated by GSK3β phosphorylation. Moreover, overex-
pression of T/D-CRMP-2 in cre+GSK3βlox/lox neurons re-
versed their increased microtubule growth speed (Figure 7J,
see also Additional file 7: Movie S5), which correlated with
a decreased axon growth [see Additional file 8: Movie S6
and Additional file 9: Figure S3] and a decreased ratio of
acetylated/tyrosinated microtubules (Figure 7K,L). Com-
bined, these results demonstrate that neuronal deletion of
GSK3β alters the microtubule cytoskeleton in the growth
cone, specifically by regulating the levels of P-CRMP-2.
Inactivation of the GSK3β-CRMP-2 pathway participates in
the conditioning effect attenuating the growth repression
mediated by CNS inhibitors
In conditioned DRG neurons, enhanced axonal growth
and increased microtubule growth speed in the growth
cone are present. At the molecular level, we determined
that inhibition of GSK3β activity and decreased levels of
P-CRMP-2 occurred in this model. To further demon-
strate that the GSK3β-CRMP-2 pathway is critical for the
conditioning effect, we transfected conditioned DRG neu-
rons with the phospho-mimetic mutant T/D-CRMP-2.
Overexpression of phospho-mimetic CRMP-2 partially
reversed the increased microtubule growth speed of con-
ditioned neurons (Figure 8A, see also Additional file 1:
Movie S1) and this effect correlated with a decrease in
neurite outgrowth (Figure 8B,C, see also Additional file 2:
Movie S2 and Additional file 3: Figure S1). A pronounced
reversion of the conditioning effect was observed at the
level of neurite formation as overexpression of T/D-
CRMP-2 in conditioned neurons led to a decrease in the
percentage of cells with neurites to levels similar to those
observed in naïve neurons (Figure 8D). We next assessed
whether reducing the levels of P-CRMP-2 by overexpres-
sion of T/A-CRMP-2 affected myelin-mediated inhibition
of neurite outgrowth in naïve DRG neurons. As expected,
purified CNS myelin decreased the growth of the longest
DRG neurite (Figure 8E,F). Interestingly, overexpression
of phospho-resistant T/A-CRMP-2 counteracted the in-
hibitory effect of myelin (Figure 8E,F). Together these
results demonstrate that inactivation of the GSK3β-CRMP-
2 pathway participates in the conditioning effect overcom-
ing the growth repression mediated by CNS inhibitors.
Discussion
A conditioning lesion reprograms neurons to a regenera-
tive status. So far, none of the molecules identified as play-
ing a role in this paradigm was shown to be sufficient and
necessary to mimic the gain of axonal regenerative cap-
acity elicited, probably as it is obtained through the com-
bination of multiple components. As such, the quest for
clinically relevant molecules that contribute to the condi-
tioning lesion effect should be pursued. In this work,
we show that the GSK3β-CRMP-2 pathway participates
in this paradigm, with decreased GSK3β activity and
phospho-CRMP-2 levels promoting axonal regeneration
and attenuating the growth repression mediated by CNS
inhibitors. The effect of a conditioning lesion in increasing
the microtubule growth speed is more robust than that of
GSK3β deletion alone, which supports that other path-
ways might participate in this effect, as is the case in
HDAC5 activation [5].
At the mechanistic level, we demonstrate that in vivo,
both in WT animals and by blocking Ser9 phosphoryl-
ation, GSK3β inhibition occurs through regulation of
P-Tyr216 levels. A dual mechanism for the regulation of
phosphorylated GSK3βTyr216 is probably in place after
SCI, as increased specific phosphatase activity and de-
creased Fyn kinase levels are observed in conditions of
increased axonal growth. In contrast to our data, after
nerve crush injury, both GSK3β P-Ser9 and P-Tyr216
have been reported to be increased both in ipsilateral
and contralateral nerves, which causes difficulties in the
interpretation of the results [29]. Recently, regulation of
axon regeneration through PI3K-GSK3 signaling, occur-
ring through induction of Smad1 expression, was shown
to be specific in the soma but dispensable for local axon
assembly in the distal axons. Interestingly, this suggested
the existence of upstream regulators responsible for
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modulating GSK3 signaling in growth cones of adult
sensory neurons [30]. In this respect, we now show that
regulation of P-GSK3βTyr216 levels, achieved by the
dual action of upstream kinases and phosphatases, is a
possible mechanism responsible for modulating GSK3
activity specifically in growth cones.
Although several studies attempted to understand the
role of GSK3β in axon growth and regeneration, as re-
cently reviewed [31], most of the reports used cultured
neurons or neuronal cell lines, and semi-specific pharma-
cological inhibitors, yielding conflicting results ranging
from promotion of axon growth to axon growth inhibition.
Some in vitro studies suggested that reduced GSK3β
activity is required for axon formation, elongation or de-
creased retraction [28,32-36], in a CRMP-2-dependent
mechanism [28,36]. Accordingly, in vivo studies using
GSK3β inhibitors showed increased axon regeneration fol-
lowing spinal cord injury [14]. Supporting that in vivo
GSK3β inactivation promotes axon regeneration, acutely
blocking PI3K signaling or depleting Smad1 in adult mice
prevented sensory axon regeneration [30]. Along the same
line, other studies suggested that increased GSK3β activity
leads to neurite retraction [37]. However, a second group
of studies reported opposite effects supporting that in-
creased GSK3β activity leads to increased axon elongation.
In this respect, high phosphorylation of GSK3 targets
Figure 8 The GSK3β-CRMP-2 pathway participates in the conditioning lesion effect. (A) Quantification of microtubule growth speed in
naïve and conditioned (CL) DRG neurons transfected with EB3-GFP, or conditioned neurons co-transfected with EB3-GFP and T/D-CRMP-2
(CL + T/D-CRMP-2); (n = 140 to 170 microtubules). (B) Quantification of the average size of the longest neurite in naïve and conditioned (CL)
DRG, or conditioned neurons overexpressing T/D-CRMP-2 (CL + T/D-CRMP-2); (n = 40 to 91). (C) Representative images of C. Scale bar: 100 μm.
(D) Quantification of the percentage of cells with neurites in naïve and conditioned (CL) DRG, or conditioned neurons overexpressing T/D-CRMP-2
(CL + T/D-CRMP-2). (E) Quantification of the size of the longest neurite of DRG neurons plated on top of laminin (control) or laminin +myelin (myelin),
either transfected with pEGFP-C1 or co-transfected with pEGFP-C1 and T/A-CRMP-2 (myelin + T/A-CRMP-2); (n = 64 to 83). (F) Representative images
of F. Scale bar: 30 μm. All error bars are SEM. *P <0.05. **P <0.01. ***P <0.001. One way ANOVA. ANOVA, analysis of variance; CRMP, collapsin response
mediator protein; DRG, dorsal root ganglia; GFP, green fluorescent protein; GSK3β, glycogen synthase kinase 3β; SEM, standard error of the mean.
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(including CMRP-2) was shown to increase neurite elong-
ation [38-40] and pharmacological inhibition or small hair-
pin RNA (shRNA) blockage of GSK3β activity was
reported to induce neurite retraction [15,41,42], with par-
ticipation of CRMP-4 in the inhibitory effects [15]. The
discrepancies in the literature were reconciled with the
concept that the final outcome of GSK3β inhibition would
depend on the extent of inhibition. In this paradigm, partial
inactivation of GSK3β in the growth cone would lead to ef-
ficient axonal elongation, while strong inhibition would
lead to suppression of kinase activity all along the axon,
blocking axonal growth [43]. However, as recently sug-
gested [31], a complete understanding of the role of GSK3β
in axon growth and regeneration required additional ex-
perimentation using in vivo genetic models, as was per-
formed in the current work. Here, we demonstrate that
in vivo not only reduced GSK3β activity results in in-
creased axon regeneration, but also, by using the cre
+GSK3βlox/lox mice, we show that total ablation of GSK3β
increases axonal regeneration, ruling out the need of a
GSK3β gradient to enable axonal growth.
Given the wide array of GSK3β substrates, several stud-
ies have probed the downstream molecular mechanism
by which GSK3β controls axonal growth. As referred to
above, one of the working models was that GSK3β activity
should be precisely controlled so that activity towards one
subset of substrates would be specifically blocked, while
activity towards others would be preserved [43]. In this
model, inhibition of GSK3β activity towards CRMP-2
would allow its binding to microtubules promoting their
polymerization, while maintenance of the activity towards
MAP1B would maintain microtubules in a dynamic state,
essential for axon growth. More recently, another model
proposed CLASPs as the physiological target of GSK3 to
exert control over axon growth [44]. In this model, pro-
motion of axon growth occurred via moderate inhibition
of GSK3 activity leading to the non-phosphorylation of
some, but not all, GSK3 sites in CLASPs. This would allow
CLASPs to specifically associate with microtubule plus
ends promoting their stabilization [44]. Both models re-
quired partial inhibition of GSK3β to promote axonal
growth and regeneration. However, we demonstrate that
total GSK3β inhibition promotes axonal growth in vivo
with a concomitant increase in microtubule growth speed
in the growth cone. In this context, we show that the
effects of GSK3β deletion are not mediated by decreased
P-CLASP2 as in WT neurons, a non-phosphorylatable
CLASP2 mutant leads to increased microtubule sta-
bilization. Moreover, our results show that phosphoryl-
ation of MAP1B, although being sufficient to increase
microtubule growth speed, is unnecessary for this effect.
Interestingly, after SCI, increased levels of phosphorylated
MAP1B have been reported in retraction bulbs of trans-
ected axons and in pre-apoptotic axotomized neuronal
somata [45]. In our settings, overexpression of WT MAP1B
did not influence microtubule growth speed. MAP1B was
recently shown to interact with EB1/3 and to sequester
these proteins [46]. Nevertheless, in that report, micro-
tubule growth speed of MAP1B knockout hippocampal
neurons was unaffected in the growth cone [46]. In DRG
neurons from MAP1B knockout mice, whereas no dif-
ferences were found in the overall neurite length,
higher branching and impaired growth cone turning
were present [47]. These data suggest that rather than
playing a role in neurite growth, MAP1B is important
for growth cone turning and branch formation during
plastic changes in the adult.
More importantly, our results show that CRMP-2 is
the primary downstream target of GSK3β that mediates
the regulation of microtubule dynamics in the growth
cone as demonstrated by reversion of increased micro-
tubule growth speed of GSK3β-depleted neurons upon
overexpression of a phospho-mimetic CRMP-2 mutant.
Moreover, we demonstrate that the GSK3β-CRMP-2
pathway participates in the conditioning lesion effect, as
overexpression of the phospho-mimetic T/D-CRMP-2
mutant partially reversed the increased microtubule growth
speed of conditioned neurons leading to decreased axonal
growth, and overexpression of the phospho-resistant T/A-
CRMP-2 mutant attenuated the inhibitory effect of myelin
in naïve DRG neurons. Besides being phosphorylated by
GSK3β at Thr514 [39], CRMP-2 is also phosphorylated by
Rho-associated protein kinase (ROCK) but at an alternative
residue, Thr555 [48], downstream of both Myelin-associ-
ated glycoprotein (MAG) and Nogo-66 [49]. Interestingly,
repulsive guidance molecule A (RGMa) inhibits axon
growth by inducing CRMP-2 phosphorylation via both
ROCK and GSK3β signaling [36]. However, in that study,
details on which CRMP-2 phosphorylation (Thr514 or
Thr555) was assessed are lacking, and GSK3β inhibition
was performed in cultured neurons using a GSK3β anti-
body in the media and not a specific cell-permeable GSK3β
inhibitor. Taken together, our data demonstrate that, irre-
spective of ROCK-mediated CRMP-2 phosphorylation at
Thr555, inactivation of CRMP-2 phosphorylation at
Thr514 by GSK3β is sufficient to reverse myelin inhibition
in DRG neuron cultures. Our results point towards
modulation of CRMP-2 activity as a therapeutic target
to induce axonal regeneration. Further suggesting that
CRMP-2 is a central target to design strategies to achieve
release of myelin inhibition, overexpression of the
phospho-resistant mutant T555A-CRMP-2 (the Rho-
kinase phosphorylation site) counteracts the inhibitory ef-
fect of MAG on postnatal cerebellar neurons [49]. Add-
itionally, protein phosphatase 2A promotes axonal growth
by dephosphorylating CRMP-2 [50]. The involvement of
CRMP-2 in several neurodegenerative diseases raised the
need for developing therapeutic strategies targeting its
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functions. In this respect, drugs regulating CRMP-2 levels
and activity are currently being tested in the settings of
neurodegeneration [51].
Conclusions
Our work shows that microtubule dynamics in the
growth cone are higher in conditions of increased axonal
growth, such as after conditioning lesion. This alteration
is achieved following inactivation of the GSK3β-CRMP-2
pathway and is accompanied by enhanced axon regener-
ation through the glial scar. Based on the present results,
studying the effect of CRMP-2-specific drugs, capable of
modulating its activity, should be further developed in
SCI and in other conditions where axonal regeneration
needs to be promoted.
Methods
Animals
All animal experiments were performed according to na-
tional and European rules. The protocols described in this
work have been approved by the IBMC Ethical Committee
and by the Portuguese Veterinarian Board. GSK3β knock-
out heterozygous mice (GSK3β(+/−)) [17] were bred with
C57/B6 mice and the resulting GSK3β(+/−) and WT
littermates were selected as described [17]. Homozygous
GSK3β Ser9Ala knockin (KI) mice, where codon encoding
Ser9 of GSK3β was changed to encode the nonphosphory-
latable Ala residue, were a kind gift from Dr Dario Alessi,
Dundee University [16]. To generate experimental GSK3β
Ser9Ala KI and the respective WT control mice, GSK3β
Ser9Ala KIs were initially crossed with C57/B6 mice and
the resulting GSK3β Ser9Ala heterozygous KI mice were
inter-crossed such that GSK3β Ser9Ala KI and WT ani-
mals were generated and selected as described [16].
GSK3β floxed mice (GSK3βlox/lox) [22] and Slick-H mice
(a kind gift from Dr Guoping Feng, Duke University
Medical Center; mice that coexpress inducible-CreERT2
and YFP under the control of the Thy1 promoter [23])
were used to generate neuronal-specific conditional GSK3β
knockout mice (cre+GSK3βlox/lox). For that, GSK3βlox/
lox were crossed with Slick-H mice. Cre+GSK3βlox/wt
mice were selected and then crossed to GSK3βlox/wt mice
such that cre+GSK3βlox/lox and cre+GSK3βwt/wt mice
were generated. Given the neuroprotective effects of
tamoxifen [52,53], tamoxifen-treated cre+GSK3βlox/lox
animals were compared to tamoxifen-treated cre+GSK3βwt/
wt mice. In all experiments animals of either sex were used.
Surgeries
For sciatic nerve injury, the sciatic nerve was transected at
the mid thigh level. For spinal cord injury (SCI), laminec-
tomy was performed at the T7 level in rats and at the T9/
10 level in mice; dorsal hemisection or complete spinal
cord transection were done using a micro feather
ophthalmic scalpel. For conditioning lesion, animals were
subjected to sciatic nerve transection and one week later
to dorsal spinal cord hemisection.
Phospho-site broad signaling pathway screen
DRGs (L4-L6) from a pool of six rats eight- to ten-
weeks-old subjected to either SCI (dorsal hemisection)
or conditioning lesion (CL) were sacrificed one week
after SCI. DRG were homogenized in lysis buffer (20 mM
4-morpholinepropanesulfonic acid (MOPS), 2 mM ethyl-
ene glycol tetraacetic acid (EGTA), 5 mM ethylenedi-
aminetetraacetic acid (EDTA), 30 mM NaF, 60 mM
β-glycerophosphate, 20 mM sodium pyrophosphate,
1 mM sodium orthovanadate, 1% Triton X-100, 1% dithio-
threitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF)
and protease inhibitor cocktail (GE Healthcare, Carnax-
ide, Portugal)). Protein extracts (500 μg) were analyzed
using the Kinexus phospho-site broad signaling pathway
screen version 1.3 (KPSS-1.3, Kinexus Bioinformatics
Corp, Vancouver, Canada). This screen examines 38 phos-
phorylation sites in 32 proteins with antibodies that
recognize specific phosphorylated epitopes. The intensities
of signals for target protein bands on the Kinetworks im-
munoblots were quantified as described [54]. Proteins
with a fold change CL/SCI lower than 0.75 or higher than
1.25 were selected.
Western blotting
DRGs (L4-L6) and the SCI site (3 mm rostral and 3 mm
caudal to the lesion site) from either eight- to ten-week-
old rats or WT and GSK3βSer9Ala KI mice with SCI or
conditioning lesion were processed as described above.
Lysates of neuronal cultures overexpressing GSK3β sub-
strates (as described below) were prepared in phosphate-
buffered saline (PBS) with 0.03% triton, 1 mM sodium
orthovanadate and protease inhibitor cocktail. Protein
lysates (25 to 50 μg/lane) were separated on either 12%
or 3% to 8% gradient (in the case of MAP1B and
CLASP2) SDS-PAGE gels and transferred to nitrocellu-
lose (Amersham, Carnaxide, Portugal). Membranes
were blocked and incubated overnight at 4°C in 5% bo-
vine serum albumin (BSA) in tris-buffered saline with
Tween (TBST) with the following primary antibodies:
rabbit anti-P-AktSer473 (1:2000; Cell Signaling, Leiden,
The Netherlands), rabbit anti-Akt (1:1000; Cell Signaling),
rabbit anti-P-GSK3βSer9 (1:1000; Cell Signaling), rabbit
anti-P-GSK3βTyr216 (1:2000; Santa Cruz Biotechnology,
Heidelberg, Germany), mouse anti-GSK3α/β (1:3000;
Santa Cruz Biotechnology), sheep anti-P-CRMP-2Thr509/
514 (1:1000, Kinasource), sheep anti-CRMP-2 (1:500,
Kinasource), rabbit anti-P-SrcTyr529 (1:500, Signalway
antibody), rabbit anti-Fyn (1:1000, Cell Signaling), goat
anti-Pyk2 (1:1000, Santa Cruz Biotechnology), rabbit anti-
MAP1B (1:2500, kindly provided by Dr Itzhak Fischer,
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Drexel University College of Medicine, Philadelphia, PA,
USA), rat anti-CLASP2 (kindly provided by Dr Helder
Maiato, IBMC, Porto, Portugal), mouse anti-α-tubulin
(1:5000, Sigma-Aldrich, Sintra, Portugal), mouse anti-β-actin
(1:1000, Sigma-Aldrich) and mouse anti-glyceraldehyde 3-
phosphate dehydrogenase (1:2000, Santa Cruz Biotechnol-
ogy). Incubation with horseradish peroxidase-labeled
secondary antibodies was performed for one hour at room
temperature. Blots were developed using the enhanced
chemiluminescence Western blot substrate (Pierce). Quanti-
fication was performed using the QuantityOne software
(Bio-rad, Amadora, Portugal). For each experiment repre-
sentative Western blots are shown.
GSK3β activity assays
A commercial kit (Sigma) was used for GSK3β activity
assays. The samples analyzed were: the SCI site of
eight- to ten-week-old rats with SCI or conditioning le-
sion, and the spinal cord (T8-T10) from eight-week-old
GSK3βSer9Ala KI mice, GSK3β(+/−) mice or the re-
spective WT controls. Briefly, 250 μg of protein lysate
(n = 3 samples/condition) were incubated with the pro-
vided anti-GSK3β antibody in Protein G beads for three
hours at 4°C. The kinase assay was performed in the
immunoprecipitates using a GSK3β substrate and γ-32P-ATP.
Control reactions without GSK3β antibody were performed.
Results are presented as fold change relative to controls.
Measurement of phosphatase activity
Phosphatase activity of the SCI site from eight- to ten-week-
old rats with either SCI or conditioning lesion (n = 3 per
condition) was assayed in 96-well microtiter plates using
a tyrosine phosphatase assay system (Promega, Carnaxide,
Portugal). Protein extracts (25 μg) were incubated with
100 μM of a P-GSK3βTyr216 peptide (Abcam, Cambridge,
UK) at 30°C for 30 minutes. The released phosphate was
determined by measuring the absorbance at 620 nm.
Control reactions without the P-GSK3βTyr216 peptide were
performed.
Primary cultures of DRG neurons and neurite outgrowth
assays
Primary cultures of DRG neurons were performed as de-
scribed [55]. Briefly, all DRG (when analyzing naïve neu-
rons) or L4-L6 DRG (when comparing naïve with
conditioned neurons that is, neurons obtained from ani-
mals with sciatic nerve transection performed one week
before DRG removal) from eight- to ten-week-old Wistar
rats, or whenever indicated, from GSK3β genetic mouse
models, were cultured for 12 hours. For transfection, the
4D Nucleofector Amaxa system (Lonza, Barcelona, Spain,
CM#138 program) was used with 0.4 μg pmaxGFP™
(Lonza) or 0.4 μg pmaxGFP™ plus 2 μg pCMV5-Fyn
Lys299Met (Fyn kinase-dead, a kind gift from Dr Marilyn
Resh, Memorial Sloan-Kettering Cancer Center, New
York, NY, USA). After transfection, cells were left in sus-
pension for 24 hours and thereafter plated in poly L lysine
(PLL)-laminin coated coverslips for 12 hours. For cultures
with myelin, DRG neurons were isolated from mice at
postnatal day 6 (P6). After transfection, DRG neurons
were left in suspension for 24 hours and thereafter plated
in PLL-laminin plus 3 μg myelin coated coverslips for
12 hours. Myelin was isolated from the spinal cord of
16-week-old WT mice as previously detailed [56].
To measure neurite outgrowth, immunocytochemistry for
βIII-tubulin was done. The length of the longest neurite
was traced with neuronJ [57]. The number of neurons
traced was: for rat DRG neurons, 77 to 136; for GSK3Ser9-
AlaKI neurons, 29 to 100; for cre+GSK3βlox/lox neurons,
48 to 66 YFP + neurons.
Overexpression of GSK3β substrates in neuronal cultures
Substrate residues phosphorylated by GSK3β were mu-
tated to generate phospho-resistant or phospho-mimetic
mutants. Mutations were generated by polymerase chain
reaction (PCR)-based site-directed mutagenesis using
QuickChange XL (Agilent Technologies, Santa Clara,
CA, USA). For MAP1B, double mutants of the residues
S1260 and T1265 were done to either Ala (ST/AA-
MAP1B) or Asp (ST/DD-MAP1B) in pEGFP-C1 bearing
full-length WT MAP1B. Neurons were co-transfected
with EB3-mCherry and each of the MAP1B constructs,
and microtubule growth speed was assessed. For CLASP2
adenoviruses, full-length WT or phosphomutant (9S/A-
CLASP2 or 8S/D-CLASP2) EGFP-CLASP2α [26] was
subcloned into pENTR/D-TOPO and recombined into
pAd/CMV/V5-DEST using Invitrogen’s Gateway system,
Carcavelos, Portugal. Adenovirus particles were generated
and purified as previously described [27,58]. For CRMP-2,
single amino acid mutations of the residue T514 to either
Ala (T/A-CRMP-2) or Asp (T/D-CRMP-2) were gener-
ated, in a construct of full-length WT CRMP-2 (FLAG
tagged at the N-terminus) cloned into the pRK5 expres-
sion vector, and co-transfections with EB3-mCherry or
pEGFP-C1 were performed. For analysis of the relative ex-
pression of each mutant, the neuronal cell line CAD was
used [59].
Analysis of microtubule growth speed
DRG neurons from eight- to ten-week-old animals were
nucleofected with either a truncated version of EB3-GFP
(a construct containing aminoacids 1 to 200 of EB3, arti-
ficially dimerized by the addition of the leucine zipper
domain of GCN4, cloned into the pEGFP-N1 vector, that
efficiently accumulates at microtubule tips [60]) or EB3-
mCherry, which contains full-length EB3 cloned into the
mCherry-N2 vector (a kind gift from Dr Victor Small,
Institute of Molecular Biotechnology, Vienna, Austria).
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After transfection, cells were left in suspension for
24 hours and then plated for 12 hours. For high reso-
lution of EB3 comets, time-lapse recordings were per-
formed for 100 frames every two seconds at 37°C on a
Spinning Disk. Extended imaging periods required to
correlate microtubule growth speed and axon growth
were done by acquisition of 129 to 230 frames every five
seconds at 37°C on a Spinning Disk. Kymographs were
made using a Matlab script (LAPSO) [61]. The comet
density (number of growing microtubules in a growth
cone) was defined by counting the number of EB3
comets per frame per growth cone area. To quantify the
distance of microtubule tips to the leading edge of the
growth cone, a plot profile for EB3 fluorescence intensity
versus distance was performed as previously described
[62]. Briefly, EB3 fluorescence was measured from the
tip of the growth cone up to 10 μm along the growth
cone using ImageJ analysis software. A minimum of 61
microtubules from at least 11 neurons was quantified.
Immunocytochemistry
DRG neurons from eight- to ten-week-old rats (either
naïve or conditioned) and naïve neurons transfected with
the Fyn kinase dead construct were fixed in either forma-
lin or 2% paraformaldehyde (PFA) (in the case of trans-
fected cells). Neurons from eight-week-old GSK3β(+/−)
mice, cre+GSK3βlox/lox mice or the respective controls,
were fixed with 2% PFA in cytoskeletal protection buffer
(65 mM piperazine-N, N′-bis (2-ethanesulfonic acid)
(PIPES), 25 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES), 10 mM EGTA, 3 mM MgCl2, 0,1%
Triton X-100) for 15 minutes at room temperature. Cells
were permeabilized with 0.2% triton X-100 (with the ex-
ception of cells fixed with the cytoskeletal protection buf-
fer) and blocked with 5% normal donkey serum in PBS.
Incubation with rabbit anti-P-GSK3βTyr216 (1:20; Santa
Cruz Biotechnology), mouse anti-GSK3β (1:500; BD
Transduction Laboratories, Oeiras, Portugal), rat anti-
tyrosinated tubulin (1:100; Serotec, Oxford, UK), mouse
anti-acetylated tubulin (1:1000; Sigma), sheep anti-P-
CRMP-2Thr509/514 (1:200; Kinasourse), rabbit anti-P-
MAP1BThr1265 (1:100, Novus Biologicals Cambridge,
UK), and mouse anti-βIII-tubulin (1:2000; Promega) anti-
bodies in blocking buffer was performed for one hour at
room temperature. For calculating the intensity ratios for
P-GSK3βTyr216/GSK3β, P-CRMP-2/βIII-tubulin and P-
MAP1B/βIII-tubulin, the background of the photographs
was subtracted and images were analyzed with the ImageJ
plugin Ratio Plus generating an image where the mean
value of the intensity ratio between the two channels in
the growth cones was obtained. The ratio of acetylated
versus tyrosinated α-tubulin was determined by measuring
the fluorescence intensities of acetylated α-tubulin and of
tyrosinated α-tubulin with ImageJ. Measurements were
done in the entire growth cone area selected using the tyr-
osinated α-tubulin channel, after background subtraction
for each channel. For the cre+GSK3βlox/lox mice, only
YFP+ cells were analyzed. Data were analyzed with Prism5
(GraphPad) and the mean ± standard error of the mean
(SEM) was calculated.
Quantification of YFP-positive axons within the lesion area
In cre+GSK3βlox/lox mice, we quantified the number of
YFP+ axons within the lesion area. The same images
used for the quantification of dorsal column axons were
used. Image analysis was performed using the Fiji soft-
ware. After background subtraction, the threshold was
automatically adjusted using the ‘Li’ algorithm [63]. Sub-
sequently, the percentage of the lesion area occupied by
the YFP signal was calculated.
GSK3 immunohistochemistry
Paraffin sections of DRGs (L4 to L6) from eight-week-
old cre+GSK3βlox/lox and cre+GSK3βwt/wt mice were
blocked and incubated overnight at 4°C with the follow-
ing antibodies: anti-GSK3β (1:100; Cell Signaling), anti-
GSK3α (1:100; Cell Signaling), and anti-GFP (1:1000;
Clontech, Lisboa, Portugal). Subsequently, incubation
was performed with the respective fluorescent secondary
antibodies and slides were mounted in vectashield with
4′,6-diamidino-2-phenylindole (DAPI.
Analysis of regeneration of dorsal column fibers
Eight- to ten-week-old Wistar rats or GSK3β genetic
mouse models were subjected to spinal cord dorsal
hemisection and allowed to recover for five weeks. A
group of animals was conditioned one week prior to SCI
by transecting the left sciatic nerve. Four days prior to
euthanasia, 2 μL of 1% CT-B (List Biologicals, Campbell,
CA, USA) was injected in the left sciatic nerve. Animals
were perfused with formalin, tissues were cryopreserved
in sucrose and sectioned at 50 μm. Consecutive spinal
cord sagittal sections were collected for free floating im-
munohistochemistry with anti-CT-B (1:30000; List Bio-
logicals). Antigen detection was performed following
incubation with biotinylated horse anti-goat (1:200;
Vector, Peterborough, UK) either with extravidin perox-
idase (1:1000; Sigma) or extravidin Alexa 568 (Invitro-
gen). Image analysis was done with the Photoshop CS5
(for optical microscopy) or the Fiji software (for confocal
microscopy). Dorsal column fibers were quantified by
counting the total number of axons within the glial scar
in 1-in-3 sections. The length of the longest CT-B la-
beled axon found rostrally to the injury site, was mea-
sured using as the origin a vertical line placed at the
rostral end of the dorsal column tract (that is, where
CT-B labeling accumulates). Lesion margins were evi-
dent under phase-contrast optics as a distinct change in
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the appearance of the structure of the white and grey
matter was observed. Total axon number/animal was
calculated by multiplying the counted number by three.
Analysis of regeneration of raphespinal serotonergic axons
Eight- to ten-week-old GSK3β(+/−) mice and WT litter-
mates were subjected to complete spinal cord transection
and allowed to recover for five weeks. Free floating immu-
nohistochemistry with rabbit anti-5-HT (1:20000; Immu-
nostar, Hudson, WI, USA) was performed. Images were
taken on a confocal microscope (Leica) and analysis was
done with Fiji. 5-HT + axons were quantified along the
rostral-caudal axis by counting the total number of axons
in a 3,000 μm area caudal to the injury site in eight to ten
sections per animal. Cross-sections from uninjured spinal
cords obtained at the T7 level were also processed for 5-
HT immunostaining as above and 5-HT immunoreactivity
was quantified in four sections/animal using FeatureJ soft-
ware and normalized for the total area of the spinal cord.
The glial scar area was evaluated using an anti-GFAP anti-
body (1:500, DAKO, Queluz, Portugal). The injury area,
corresponding to the GFAP-negative area, was measured
using Photoshop CS5.
Behavioral assessment
Eight- to ten-week-old animals with complete transection
of the spinal cord were assessed for locomotor recovery
using the Basso mouse scale [64] at day one and weekly
until five weeks after the injury. The observer was blinded
to the animal’s genotype.
Data analysis
Data are shown as mean ± SEM. Statistical significance was
determined by Student’s t test or Tukey’s test (one-way
analysis of variance (ANOVA)).
Additional files
Additional file 1: Movie S1. Time-lapse live cell imaging of DRG
neurons either naïve or conditioned (CL) transfected with GFP-EB3, and
conditioned DRG neurons transfected with GFP-EB3 plus T/D-CRMP-2
(CL + T/D-CRMP2), taken using an Andor Revolution XD Spinning Disk
confocal microscope. Scale bar: 5 μm. Total time: 200 seconds. Acquired
at one frame per two seconds. 30x speed up.
Additional file 2: Movie S2. Extended time-lapse live cell imaging of
DRG neurons either naïve or conditioned (CL) transfected with GFP-EB3,
and conditioned DRG neurons transfected with GFP-EB3 plus T/D-CRMP-2
(CL + T/D-CRMP2), taken using an Andor Revolution XD Spinning Disk
confocal microscope. Scale bar: 5 μm. Total time: 770 seconds. Acquired
at one frame per five seconds. 75x speed up.
Additional file 3: Figure S1. Still frames from the extended time-lapse
fluorescence microscopy of naïve and conditioned (CL) DRG neurons
transfected with EB3-GFP, or conditioned neurons co-transfected with
EB3-GFP and T/D-CRMP-2 (CL+T/D-CRMP-2). Scale bar: 5 μm.
Additional file 4: Movie S3. Time-lapse live cell imaging of WT or
GSK3β(+/−) DRG neurons transfected with GFP-EB3 taken using an
Andor Revolution XD Spinning Disk confocal microscope. Scale bar: 5
μm. Total time: 200 seconds. Acquired at one frame per two seconds.
30x speed up.
Additional file 5: Movie S4. Extended time-lapse live cell imaging of
WT or GSK3β(+/−) DRG neurons transfected with GFP-EB3 taken using an
Andor Revolution XD Spinning Disk confocal microscope. Scale bar: 5
μm. Total time: 645 seconds. Acquired at one frame per five seconds.
75x speed up.
Additional file 6: Figure S2. Still frames from the extended time-lapse
fluorescence microscopy of WT or GSK3β(+/−) DRG neurons transfected
with GFP-EB3. Scale bar: 5 μm.
Additional file 7: Movie S5. Time-lapse live cell imaging of cre
+GSK3βwt/wt or cre+GSK3βlox/lox DRG neurons transfected with
mCherry-EB3 (wt/wt or lox/lox, respectively), or cre+GSK3βlox/lox DRG
neurons transfected with mCherry-EB3 plus T/D-CRMP-2 (lox/lox+T/D-
CRMP2) taken using an Andor Revolution XD Spinning Disk confocal
microscope. Scale bar: 5 μm. Total time: 200 seconds. Acquired at one
frame per two seconds. 30x speed up.
Additional file 8: Movie S6. Extended time-lapse live cell imaging of
cre+GSK3βwt/wt or cre+GSK3βlox/lox DRG neurons transfected with
mCherry-EB3 (wt/wt or lox/lox, respectively), or cre+GSK3βlox/lox DRG neurons
transfected with mCherry-EB3 plus T/D-CRMP-2 (lox/lox+T/D-CRMP2)
taken using an Andor Revolution XD Spinning Disk confocal microscope.
Scale bar: 5 μm. Total time: 1,150 seconds. Acquired at one frame per five
seconds. 75x speed up.
Additional file 9: Figure S3. Still frames from the extended time-lapse
fluorescence microscopy of cre+GSK3βwt/wt or cre+GSK3βlox/lox DRG
neurons transfected with mCherry-EB3 (wt/wt or lox/lox, respectively), or
cre+GSK3βlox/lox DRG neurons transfected with mCherry-EB3 plus T/D-
CRMP-2 (lox/lox+T/D-CRMP2). Scale bar: 5 μm.
Additional file 10: Movie S7. Time-lapse live cell imaging of rat WT
naïve neurons expressing mCherry-EB3 alone (control) or with WT MAP1B,
ST/AA-MAP1B or ST/DD-MAP1B, taken using an Andor Revolution XD Spinning
Disk confocal microscope. Scale bar: 5 μm. Total time: 200 seconds.
Acquired at one frame per two seconds. 30x speed up.
Additional file 11: Movie S8. Time-lapse live cell imaging of rat WT
naïve neurons expressing GFP-EB3 alone (control) or co-transfected
with WT CRMP-2, T/A-CRMP-2 or T/D-CRMP-2, taken using an Andor
Revolution XD Spinning Disk confocal microscope. Scale bar: 5 μm. Total
time: 200 seconds. Acquired at one frame per two seconds. 30x speed up.
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